Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients with mild-to-moderate ulcerative colitis who drank 130ml of diluted Montmo ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

When you have ulcerative colitis, your need for a bathroom break ... In many people, the symptoms are mild to moderate. And there are treatments that can help. There may be times when you need ...

The American Gastroenterological Association (AGA) has recently released a major update to its clinical guideline for the ...

for induction treatment of moderate-to-severe ulcerative colitis (UC), with patients who failed on immunomodulators, anti-TNFα, vedolizumab or corticosteroids. The topline results indicate that ...

Although the appendix is generally believed to be a vestigial organ, there is growing evidence pointing to its possible role in modulating gut immunity and microbial homoeostasis.1,2 These roles have ...

A significant proportion of children newly diagnosed with IBD present with anaemia, and many of them remain anaemic even ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is s ...

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from ...